Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan).

Authors not listed

Pfizer · 2008

Abstract

The objective of this surveillance is to collect information about 1) adverse drug reaction not expected from the LPD (unknown adverse drug reaction), 2) the incidence of adverse drug reactions in this surveillance, and 3) factors considered to affect the safety and/or efficacy of this drug.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-08 MST

Cite this

APA
Anonymous. (2008). Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan). <em>Pfizer</em>. https://clinicaltrials.gov/study/NCT00845273
Vancouver
Anonymous. Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan). Pfizer. 2008.
BibTeX
@misc{anon2008Specia, title = {Special Investigation For Long-term Use Of Macugen (Regulatory Post Marketing Commitment Plan).}, author = {Anonymous}, journal = {Pfizer}, year = {2008}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings